seekingalpha.com
Oakmark International Strategy Q4 2025 New Investments And Divestments
Oakmark International Strategy Q4 2025 New Investments And Divestments
SYIEFSYIEFOTC
Loading
Latest News
Loading news...
zacks.com
What Makes Symrise (SYIEY) a New Buy Stock
Symrise (SYIEY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
defenseworld.net
Axalta Coating Systems (NYSE:AXTA) vs. Symrise (OTCMKTS:SYIEY) Head to Head Analysis
Axalta Coating Systems (NYSE: AXTA - Get Free Report) and Symrise (OTCMKTS:SYIEY - Get Free Report) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, valuation and profitability. Earnings and Valuation This table compares Axalta
seekingalpha.com
Harding Loevner International Equity ADR Q3 2025 Portfolio Update
The International Equity ADR composite rose 3.0% gross of fees in the second quarter, behind the 7.0% gain of the MSCI ACWI ex US Index. In Communication Services, Tencent delivered a second consecutive quarter of double-digit revenue and profit growth. Japan was the largest detractor, with Chugai and Sysmex weighing on results.
seekingalpha.com
The Moat Might Be Narrow, But Symrise Looks Undervalued (Rating Upgrade)
Symrise AG is now rated a 'Buy' as the stock trades below intrinsic value after a 30% decline from previous coverage. Despite recent sales declines due to FX headwinds, SYIEF demonstrated organic growth, improved margins, and consistent long-term revenue and earnings expansion. Management and analysts project 5-7% organic sales growth and stable margins, supported by industry growth drivers and Symrise's historical performance.
seekingalpha.com
Symrise AG (SYIEF) H1 2025 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) H1 2025 Earnings Call July 30, 2025 5:00 AM ET Company Participants Jean-Yves Parisot - CEO, Head of Scent & Care and Member of Executive Board Olaf Klinger - CFO, Head of Finance, Legal & IT Department and Member of Executive Board Rene Weinberg - Head of Investor Relations Conference Call Participants Alexander Morrow Sloane - Barclays Bank PLC, Research Division Charles Eden - UBS Investment Bank, Research Division Edward G. Hockin - JPMorgan Chase & Co, Research Division Lisa Hortense Maria De Neve - Morgan Stanley, Research Division Matthew John Peter Yates - BofA Securities, Research Division Nicola Tang - BNP Paribas Exane, Research Division Ranulf Orr - Citigroup Inc., Research Division Operator Ladies and gentlemen, welcome to the Symrise H1 2025 Analyst and Investor Call.
globenewswire.com
Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP
HBC will accelerate its manufacturing scale and market reach with the construction of a second enzymatic hydrolysis plant in Berkåk, Norway. Symrise will support the financing of the project through a EUR 5m loan. The partnership ideally complements both HBC and Symrise's current portfolio with science-led, clinically proven marine ingredients for Consumer Health. HBC have also signed an exclusive distribution agreement for OmeGo®, ProGo® and NT-II™ into the Consumer Health and Functional Food categories for four of Symrise's global key accounts.
seekingalpha.com
Symrise AG (SYIEF) Q3 2024 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) Q3 2024 Earnings Conference Call October 24, 2024 2:00 AM ET Company Participants Jean-Yves Parisot - President, Taste Nutrition & Health & Incoming CEO Olaf Klinger - CFO Conference Call Participants Matthew Yates - Bank of America Merrill Lynch Ed Hockin - JPMorgan Charles Eden - UBS Isha Sharma - Stifel Nicola Tang - BNP Paribas Charles Bentley - Jefferies Oliver Schwarz - Warburg Research Operator Ladies and gentlemen, welcome to the trading update in January, September 2024 Conference Call. I'm George, the Chorus Call operator.
seekingalpha.com
Symrise AG (SYIEF) Q2 2024 Earnings Call Transcript
Start Time: 05:00 January 1, 0000 6:03 AM ET Symrise AG (OTCPK:SYIEF) Q2 2024 Earnings Conference Call August 01, 2024, 05:00 AM ET Company Participants Olaf Klinger - Chief Financial Officer Jean-Yves Parisot - President, Taste Nutrition & Health & Incoming Chief Executive Officer Tobias Erfurth - Head, Investor Relations Conference Call Participants Lisa De Neve - Morgan Stanley Charles Eden - UBS Nicola Tang - BNP Paribas Exane Matthew Yates - Bank of America Edward Hockin - JPMorgan Isha Sharma - Stifel Ranulf Orr - Citi Operator Ladies and gentlemen, welcome and thank you for attending the Investor and Analyst Conference Call on the publication of Symrise AG's Half Year Results 2024. I am Alice, the conference call operator.
seekingalpha.com
European Dividend Gems: Symrise AG
Symrise is one of the top players in the highly concentrated aroma molecules, flavours, and fragrances market. Ingredients from this company are used in products we use on a daily basis, resulting in steadily increasing sales and strong margins.